These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 10325662)

  • 1. Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial.
    Dougados M; Gueguen A; Nakache JP; Velicitat P; Veys EM; Zeidler H; Calin A
    Rheumatology (Oxford); 1999 Mar; 38(3):235-44. PubMed ID: 10325662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis.
    Dequeker J; Hawkey C; Kahan A; Steinbrück K; Alegre C; Baumelou E; Bégaud B; Isomäki H; Littlejohn G; Mau J; Papazoglou S
    Br J Rheumatol; 1998 Sep; 37(9):946-51. PubMed ID: 9783758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 4-week, double-blind, parallel-group study to compare the gastrointestinal effects of meloxicam 7.5 mg, meloxicam 15 mg, piroxicam 20 mg and placebo by means of faecal blood loss, endoscopy and symptom evaluation in healthy volunteers.
    Patoia L; Santucci L; Furno P; Dionisi MS; Dell'Orso S; Romagnoli M; Sattarinia A; Marini MG
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():61-7. PubMed ID: 8630640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling therapeutic strategies in the treatment of osteoarthritis: an economic evaluation of meloxicam versus diclofenac and piroxicam.
    Tavakoli M
    Pharmacoeconomics; 2003; 21(6):443-54. PubMed ID: 12678570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.
    Hawkey C; Kahan A; Steinbrück K; Alegre C; Baumelou E; Bégaud B; Dequeker J; Isomäki H; Littlejohn G; Mau J; Papazoglou S
    Br J Rheumatol; 1998 Sep; 37(9):937-45. PubMed ID: 9783757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic comparison of the gastroduodenal safety and the effects on arachidonic acid products between meloxicam and piroxicam in the treatment of osteoarthritis.
    Chang DM; Young TH; Hsu CT; Kuo SY; Hsieh TC
    Clin Rheumatol; 2001; 20(2):104-13. PubMed ID: 11346221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meloxicam.
    Fleischmann R; Iqbal I; Slobodin G
    Expert Opin Pharmacother; 2002 Oct; 3(10):1501-12. PubMed ID: 12387696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of meloxicam in an observational, controlled cohort study in patients with rheumatic disease.
    Degner F; Sigmund R; Zeidler H
    Clin Ther; 2000 Apr; 22(4):400-10. PubMed ID: 10823362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meloxicam in acute episodes of soft-tissue rheumatism of the shoulder.
    Vidal L; Kneer W; Baturone M; Sigmund R
    Inflamm Res; 2001 Mar; 50 Suppl 1():S24-9. PubMed ID: 11339517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal tolerability of meloxicam and piroxicam: a double-blind placebo-controlled study.
    Lipscomb GR; Wallis N; Armstrong G; Rees WD
    Br J Clin Pharmacol; 1998 Aug; 46(2):133-7. PubMed ID: 9723821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind study to compare the efficacy and safety of meloxicam 15 mg with piroxicam 20 mg in patients with osteoarthritis of the hip.
    Lindén B; Distel M; Bluhmki E
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():35-8. PubMed ID: 8630634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the local tolerability, safety and efficacy of meloxicam and piroxicam suppositories in patients with osteoarthritis: a single-blind, randomized, multicentre study.
    Carrabba M; Paresce E; Angelini M; Galanti A; Marini MG; Cigarini P
    Curr Med Res Opin; 1995; 13(6):343-55. PubMed ID: 8829892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis.
    Cheng TT; Lai HM; Chiu CK; Chem YC
    Clin Ther; 2004 Mar; 26(3):399-406. PubMed ID: 15110132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of endoscopic gastric mucosa features after administration of piroxicam to meloxicam and their correlation with dyspepsia symptoms in elderly patient with knee osteoarthritis.
    Girawan D; Abdurachman SA; Djumhana A; Roslia J; Pramudiyo R
    Acta Med Indones; 2004; 36(4):202-6. PubMed ID: 15673949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meloxicam--a safer NSAID?
    Drug Ther Bull; 1998 Aug; 36(8):62-4. PubMed ID: 9876404
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and efficacy of meloxicam in the treatment of osteoarthritis: a 12-week, double-blind, multiple-dose, placebo-controlled trial. The Meloxicam Osteoarthritis Investigators.
    Yocum D; Fleischmann R; Dalgin P; Caldwell J; Hall D; Roszko P
    Arch Intern Med; 2000 Oct; 160(19):2947-54. PubMed ID: 11041902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE study.
    Dougados M; Wood E; Combe B; Schaeverbeke T; Miceli-Richard C; Berenbaum F; Koppiker N; Dubanchet A; Logeart I
    Arthritis Res Ther; 2014 Nov; 16(6):481. PubMed ID: 25428762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aquaporin-1 expression as an indicator in evaluating the efficacy of meloxicam in the treatment of ankylosing spondylitis: A comparative study.
    Pan JE; Xiong FL; Chen G; Zhang ZW; Xu YJ
    Biomed Pharmacother; 2017 Nov; 95():1549-1555. PubMed ID: 28950654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability of multiple administration of intramuscular meloxicam: a comparison with intramuscular piroxicam in patients with rheumatoid arthritis or osteoarthritis.
    Ghozlan PR; Bernhardt M; Vélicitat P; Bluhmki E
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():51-5. PubMed ID: 8630638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of clinical trials and benefit/risk ratio of meloxicam.
    Barner A
    Scand J Rheumatol Suppl; 1996; 102():29-37. PubMed ID: 8628979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.